Beckman Coulter
Beckman Coulter develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing.
Company Description
Beckman Coulter develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing. Our diagnostic systems are found in hospitals and other critical care settings around the world and produce information used by physicians to diagnose disease, make treatment decisions, and monitor patients. Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs. Hospital laboratories are our core clinical diagnostic customers. Our life science customers include pharmaceutical and biotechnology companies, medical schools, and research institutions. Beckman Coulter has an installed base of more than 200,000 clinical and research systems operating in laboratories around the world. About 81% of Beckman Coulter's $3.3 billion annual revenue comes from recurring sources, such as consumable supplies (including reagent test kits), service and lease payments.
Chief Chromatographic Techniques Supported
- Capillary electrophoresis
- Protein analysis, CE-SDS, cIEF
- Analytical ultracentrifugation
- Carbohydrate analysis
- Ion analysis
- Chiral analysis
- UV-Visible spectroscopy
- Centrifugation
- Liquid handlers
- Particle characterization
- pH meters
- Flow cytometry
Markets Served
- Research and Development
- QA/QC
- Biopharmaceutical
- Forensics
- Academia
- Government
- Agricultural
- Industrial
- Clinical Diagnostics
Major Products/Services
Beckman Coulter provides a range of solutions to simplify, automate, and innovate complex biomedical testing. As the leader in capillary electrophoresis technology, we provide CE solutions that separate and characterize molecules, including counter-ions, nucleic acids, basic drugs, enantiomers, proteins, and carbohydrates, with high efficiency and reproducibility. Capillary electrophoresis solutions include the PA 800 plus Pharmaceutical Analysis System, PA 800 Protein Characterization System, and the P/ACE MDQ. Beckman Coulter's XL-A/XL-I Analytical Ultracentrifuge with native condition capability provides the ideal solution to satisfying the demands of the drug discovery process by characterizing a protein's behavior in free solution under physiological concentrations, temperatures, and buffer conditions.
Facilities
We conduct a variety of operations at approximately 15 owned and 121 leased facilities worldwide, including administration, R&D, hardware and consumables manufacturing, warehouse and distribution, marketing, sales, and service. Beckman Coulter's facilities often serve both our clinical diagnostics and life science segments.
Beckman Coulter
250 South Kraemer Blvd.
Brea, CA 92821
TELEPHONE
(800) 742-2345
WEB SITE
NUMBER OF EMPLOYEES
Worldwide: 11,000
YEAR FOUNDED
1935
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
